-
New Delhi, Sep 19 (SocialNews.XYZ) The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60 per cent, according to a new study.
The systematic review and meta-analysis covered 195 clinical trials of advanced cell therapies targeting COVID-19 that were conducted in 30 countries between January 2020 and December 2021, as well as 26 trials with outcomes published by July 2022.
The findings of the study, conducted by researchers at the University [...]
-
New Delhi, Sep 19 (SocialNews.XYZ) The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60 per cent, according to a new study.
The systematic review and meta-analysis covered 195 clinical trials of advanced cell therapies targeting COVID-19 that were conducted in 30 countries between January 2020 and December 2021, as well as 26 trials with outcomes published by July 2022.
The findings of the study, conducted by researchers at the University [...]
-
NotiUlti
- Publicado em 19 de setembro de 2023
El uso de terapia celular para tratar a pacientes con COVID-19 puede reducir el riesgo de muerte por la enfermedad en un 60%, según una revisión sistemática y un metanálisis realizado por investigadores de la Universidad de São Paulo (USP), en Brasil, en colaboración con colegas en Alemania y Estados Unidos.
Sus hallazgos se recogen en un artículo publicado en la revista Fronteras en inmunología.
La revisión cubre 195 [...]
-
The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60%, according to a systematic review and meta-analysis conducted by researchers at the University of São Paulo (USP) in Brazil, in partnership with colleagues in Germany and the United States.
Their findings are reported in an article published in the journal Frontiers in Immunology.
The review covers 195 clinical trials of advanced cell therapies targeting COVID-19 that were [...]
-
New Delhi, Sep 19 (SocialNews.XYZ) The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60 per cent, according to a new study.
The systematic review and meta-analysis covered 195 clinical trials of advanced cell therapies targeting COVID-19 that were conducted in 30 countries between January 2020 and December 2021, as well as 26 trials with outcomes published by July 2022.
The findings of the study, conducted by researchers at the University [...]
-
New Delhi, Sep 19 (SocialNews.XYZ) The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60 per cent, according to a new study.
The systematic review and meta-analysis covered 195 clinical trials of advanced cell therapies targeting COVID-19 that were conducted in 30 countries between January 2020 and December 2021, as well as 26 trials with outcomes published by July 2022.
The findings of the study, conducted by researchers at the University [...]
-
New Delhi, Sep 19 (SocialNews.XYZ) The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60 per cent, according to a new study.
The systematic review and meta-analysis covered 195 clinical trials of advanced cell therapies targeting COVID-19 that were conducted in 30 countries between January 2020 and December 2021, as well as 26 trials with outcomes published by July 2022.
The findings of the study, conducted by researchers at the University [...]
-
The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60%, according to a new study.
The systematic review and meta-analysis covered 195 clinical trials of advanced cell therapies targeting COVID-19 that were conducted in 30 countries between January 2020 and December 2021, as well as 26 trials with outcomes published by July 2022.
The findings of the study, conducted by researchers at the University of Sao Paulo (USP) in Brazil, in [...]
-
The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60%, according to a systematic review and meta-analysis conducted by researchers at the University of São Paulo (USP) in Brazil, in partnership with colleagues in Germany and the United States.
Their findings are reported in an article published in the journal Frontiers in Immunology.
The review covers 195 clinical trials of advanced cell therapies targeting COVID-19 that were [...]
-
New Delhi, Sep 19 (SocialNews.XYZ) The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60 per cent, according to a new study.
The systematic review and meta-analysis covered 195 clinical trials of advanced cell therapies targeting COVID-19 that were conducted in 30 countries between January 2020 and December 2021, as well as 26 trials with outcomes published by July 2022.
The findings of the study, conducted by researchers at the University [...]
